Home Applications 218643 Application 218643
Type NDA
Sponsor THEA PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CYKLX ARTICAINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC EQ 8% BASE Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218643-001 CYKLX ARTICAINE HYDROCHLORIDE EQ 8% BASE SOLUTION/DROPS / OPHTHALMIC RLD 2025-08-15
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218643-001 11096922 2039-03-27 U-4423 Drug product 2026-03-09 N218643-001 11826347 2039-03-27 U-4423 Drug product 2026-03-09 N218643-001 12403126 2039-03-27 U-4422 Drug product 2026-03-09
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N218643-001 NP 2028-08-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N218643-001 CYKLX EQ 8% BASE SOLUTION/DROPS / OPHTHALMIC RLD 2025-08-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218643-001 CYKLX EQ 8% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-08-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218643-001 CYKLX EQ 8% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-08-15 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218643-001 CYKLX EQ 8% BASE SOLUTION/DROPS / OPHTHALMIC RLD 2025-08-15 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N218643-001 11096922 2039-03-27 U-4423 Drug product 2026-03-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218643-001 11826347 2039-03-27 U-4423 Drug product 2026-03-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218643-001 12403126 2039-03-27 U-4422 Drug product 2026-03-09 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218643-001 11096922 2039-03-27 U-4423 Drug product 2026-03-09 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218643-001 11826347 2039-03-27 U-4423 Drug product 2026-03-09 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218643-001 12403126 2039-03-27 U-4422 Drug product 2026-03-09 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-18 06:07:40 2026-07 N218643-001 NP 2028-08-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218643-001 NP 2028-08-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218643-001 NP 2028-08-15 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218643-001 NP 2028-08-15 a50c72e98297…
Documents# Document, Submission type, Date table Document Submission type Date 83802 ORIG 2025-10-20 83119 ORIG 2025-08-18 83116 ORIG 2025-08-18